Koyfin Home > Directory > Health Care > Baxter International Inc

Baxter International Inc Price Chart BAX

Historical daily share price chart and data for Baxter International Inc since 1981 adjusted for splits and dividends. The latest closing price for Baxter International Inc as of November 20, 2020 is $77.02.
  • In 2020 the stock opened at $84.32 and closed at $77.02 for a loss of -9% YTD.
  • In 2019 the stock opened at $64.78 and closed at $82.95 for a gain of 22%.
  • In 2018 the stock opened at $64.20 and closed at $64.60 for a gain of 1%.
  • In 2017 the stock opened at $42.67 and closed at $62.79 for a gain of 32%.
View Chart On Koyfin

Baxter International Inc Summary

Stock Symbol: BAX

Baxter International Inc Company Info

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Market Cap
Dividend Yield
1.24 %
Beta vs SPX
Short Interest
605.46 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of BAX Prices